The partnership aims to push the boundaries of medical imaging, impact patient outcomes and increase the quality of life for Scottish patients at Dundee.
Primary results from the RADIANCE II trial were published in JAMA and results of the pooled analysis from 3 RADIANCE studies were published in JAMA Cardiolology
Hägen spent 28 years building BlackHägen Design to support clients in the development of “mission-critical” products that are both safer and easier to use.
Uhlén’s research has led to over 750 publications in scientific journals; he has founded 20 companies and has more than 70 international patent applications.